Sildenafil for pulmonary hypertension treatment after cardiac surgery

Jornal de Pediatria

Volumn 81, Issue 2, 2005, Pages 175-178

  Bentlin, Maria Regina ^a   Saito, Adriana ^a   De Luca, Ana Karina C ^a   Bossolan, Grasiela ^a   Bonatto, Rossano C ^a   Martins, Antonio S ^a   Rugolo, Ligia M S S ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Prostaglandin; Pulmonary hypertension; Sildenafil

Indexed keywords

NITRIC OXIDE; PROSTAGLANDIN E1; SILDENAFIL; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE;

ARTICLE; BLALOCK TAUSSIG ANASTOMOSIS; CARDIOVASCULAR PARAMETERS; CASE REPORT; DIAGNOSTIC PROCEDURE; DRUG DOSE REGIMEN; DRUG MECHANISM; FEMALE; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOXIA; LUNG HYPOPLASIA; NEWBORN; OXYGENATION; PULMONARY HYPERTENSION; POSTOPERATIVE PERIOD;

CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; POSTOPERATIVE PERIOD;

EID: 28244457913     PISSN: 00217557     EISSN: 00217557     Source Type: Journal    
DOI: 10.2223/1325     Document Type: Article

References (15)

1. Suguihara C. Tratamento da hipertensão pulmonar persistente do recém-nascido. J Pediatr (Rio J) 2001;77 Suppl 1:517-24.
2. Weinberger B, Weiss K, Heck DE, Laskin DL, Laskin JD. Pharmacologic therapy of persistent pulmonary hypertension of the newborn Pharmacol Ther 2001;89:67-79.
3. Crespo-Martinez C, Morales LV, Alonso RH, Alonso OB, Molero GR. Primary pulmonary hypertension and its management Farm Hosp 2004;28:48-55.
4. Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension Circulation 2001;04:424-8.
5. Shekerdemian LS, Ravn HB, Penny D. Intravenous Sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension Am J Resp Crit Care Med 2002;165: 1098-102.
6. Abrams D, Schulze-Neick I, Magee AG. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension Heart 2000;84:e4.
7. Atz AM, Wessel DL. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal Anesthesiology1999;91:307-10.
8. Erickson S, Reyes J, Bohn D, Adatia I. Sildenafil (Viagra) in childhood and neonatal pulmonary hypertension J Am Coll Cardiol 2002;39 Suppl:S402.
9. Carroll WD, Dhillon R. Sildenafil as a treatment for pulmonary hypertension Arch Dis Child 2003;88:827-8.
10. Weimann J, Ullrich R, Hromi J, Fujino Y, Clark MW, Bloch KD, et al. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension Anesthesiology2000;92: 1702-12.
11. Travardi JN, Patole SK. Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review Pediatr Pulmonol 2003;36:529-35.
12. Ghofrani HA, Wiedeman R, Rose F, Olschewski H, Chermuly RT, Weissmann N, et al. Combination therapy with oral Sildenafil and inhaled iloprost for severe pulmonary hypertension Ann Intern Med 2002;136:515-22.
13. Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S. Oral Sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension. Comparison with inhaled nitric oxide. Circulation 2002;105:2398-403.
14. Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS. Intravenous Sildenafil and inhaled nitric oxide: a randomized trial in infants after cardiac surgery Intensive Care Med 2003;29:1996-2003.
15. Long WA, Rubin LJ. Prostacyclin and PGE1 treatment of pulmonary hypertension Am Rev Respir Dis 1987;136:773-6.